See also this year's filing and all EDGAR filings for this company.
PDF Report 0001388320_2023_Actinium_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001388320, Actinium Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 110,942,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 604,000 |
| 3 | remainder_Assets | 2,646,000 |
| 4 | LiabilitiesCurrent | 10,628,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 37,083,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,999,000 |
| 9 | ResearchAndDevelopmentExpense | 23,135,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,030,000 |
| 12 | remainder_NetIncome | 1,087,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 114,192,000 |
| 1 | Liabilities | 47,711,000 |
| 2 | Expenses | 35,134,000 |
| 3 | Revenues | 1,030,000 |
| 4 | StockholdersEquity | 66,481,000 |
| 5 | NetIncome | -33,017,000 |
| 6 | ComprehensiveNetIncome | -33,017,000 |
| 7 | BaseVar | 99,577,000 |
| 8 | EconomicCapitalRatio | 1.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
